Pediani JD

Title : The pharmacology of TUG-891, a potent and selective agonist of the free fatty acid receptor 4 (FFA4\/GPR120), demonstrates both potential opportunity and possible challenges to therapeutic agonism - Hudson_2013_Mol.Pharmacol_84_710

Author(s) : Hudson BD , Shimpukade B , Mackenzie AE , Butcher AJ , Pediani JD , Christiansen E , Heathcote H , Tobin AB , Ulven T , Milligan G

Ref : Molecular Pharmacology , 84 :710 , 2013

Abstract : Hudson_2013_Mol.Pharmacol_84_710

ESTHER : Hudson_2013_Mol.Pharmacol_84_710

PubMedSearch : Hudson_2013_Mol.Pharmacol_84_710

PubMedID: 23979972

Title : Developing chemical genetic approaches to explore G protein-coupled receptor function: validation of the use of a receptor activated solely by synthetic ligand (RASSL) - Alvarez-Curto_2011_Mol.Pharmacol_80_1033

Author(s) : Alvarez-Curto E , Prihandoko R , Tautermann CS , Zwier JM , Pediani JD , Lohse MJ , Hoffmann C , Tobin AB , Milligan G

Ref : Molecular Pharmacology , 80 :1033 , 2011

Abstract : Alvarez-Curto_2011_Mol.Pharmacol_80_1033

ESTHER : Alvarez-Curto_2011_Mol.Pharmacol_80_1033

PubMedSearch : Alvarez-Curto_2011_Mol.Pharmacol_80_1033

PubMedID: 21880827

Pediani JD

References (2)

1. The pharmacology of TUG-891, a potent and selective agonist of the free fatty acid receptor 4 (FFA4\/GPR120), demonstrates both potential opportunity and possible challenges to therapeutic agonism

2. Developing chemical genetic approaches to explore G protein-coupled receptor function: validation of the use of a receptor activated solely by synthetic ligand (RASSL)